Table 4. Validation of Some Targets by qRT-PCR and Analysis of C12−HSL Effecta.
babR | vjbR | dnaK | virB2 | groEL | groES | BMEI0433 | BMEI0668 | BMEII0625 | |
---|---|---|---|---|---|---|---|---|---|
wt + ACN | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
wt + C12−HSL | 2.6 | 0.5 | 1.6 | 0.2 | 2.0 | 2.2 | 2.1 | 4.5 | 1.8 |
ΔbabR + ACN | 0 | 1.7 | 1.9 | 1.9 | 3.1 | 2.7 | 1.1 | 0.6 | 0.8 |
ΔbabR + C12−HSL | 0 | 0.3 | 1.8 | 0.1 | 4.0 | 3.3 | 0.8 | 3.5 | 2.2 |
ΔvjbR + ACN | 0.7 | 0 | 0.9 | 0.1 | 0.1 | 0.1 | 2.9 | 4.5 | 3.8 |
ΔvjbR + C12−HSL | 1.5 | 0 | 1.2 | 0.1 | 0.2 | 0.2 | 4.4 | 9.7 | 4.9 |
Comparison of fold change ratios for mRNA from wt, ΔbabR and ΔvjbR strains with or without C12−HSL. RNA was extracted at an equivalent OD600 for the transcriptomic and the qRT-PCR experiments. ACN: Acetonitrile: C12−HSL solvent. C12−HSL: dodecanoyl-L-homoserine lactone (added to the culture media at a final concentration of 5 mM). We considered that gene expression is different between wt and mutant strain when the ratio is >1.3 or <0.7.